IP Group PLC (IPO.L) stock: key figures, P/E, revenue and dividend
Financials · United Kingdom · ISIN GB00B128J450
IP Group PLC financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 69.00 m GBP | 44.90 m GBP |
| Gross profit | 0.00 GBP | 44.40 m GBP |
| Operating income | – | -56.80 m GBP |
| EBIT | 52.00 m GBP | – |
| Net income | -207.00 m GBP | 66.80 m GBP |
| Diluted EPS – continuing operations | -0.20 GBP | 0.07 GBP |
Full history since 2001, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About IP Group PLC
IP Group Plc is a private equity and venture capital firm specializing in seed/startup, early venture, emerging growth, mature, mid venture, late venture, incubation, mezzanine in growth capital companies. It prefers to invest in energy, materials, healthcare, information technology, communication services, utilities, life sciences, deeptech, cleantech, chemicals, science and innovation companies. The firm prefers to invest in Europe, typically invests in companies based in or willing to relocate to North East England. It firm prefers to invest between £0.050 million ($0.08 million) and £1.25 million ($2.01 million) with revenue up to £45 million ($71 million). IP Group Plc was founded in 2001 and is based in London, United Kingdom with additional offices in Hong Kong, Hong Kong and Melbourne, Australia.
More stocks
- Green Plains Inc. (GPRE)
- WAG Payment Solutions PLC (EWG.L)
- DroneShield Ltd (DRO.AX)
- DAKTRONICS INC /SD/ (DAKT)
- Zhejiang Oceanking Development Co Ltd (603213.SS)
- Shanghai Bailian Group Co Ltd B (900923.SS)
- Costain Group PLC (COST.L)
- Ambiq Micro, Inc. (AMBQ)
- iQIYI Inc (IQ)
- Boai NKY Pharmaceuticals Ltd (300109.SZ)
- Bide Pharmatech Co. Ltd. A (688073.SS)
- Pegavision (6491.TW)
Not investment advice. All data without warranty, price as of 05.11.2026. Details in the risk notice.